Dupixent® (Dupilumab) is a prescription injectable medication designed for the treatment of adults with moderate-to-severe eczema (atopic dermatitis) that is not adequately controlled with topical prescription therapies, or for those who are ineligible for such treatments.
Each carton includes 2 prefilled syringes, each containing 300 mg of Dupilumab in 2 mL of solution, equipped with a needle shield for safety.
Dupixent® works by targeting a key protein that contributes to the underlying inflammation in atopic dermatitis, helping to reduce the itching and redness associated with the condition.
Designed for subcutaneous injection, providing a direct approach to treatment for those struggling with severe skin conditions.
